Pharmaceutical Business Intelligence Reports
Showing 637–648 of 709 results
-
Drug Patent Reports
UBRELVY Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
UREA Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VABOMERE Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VALCHLOR Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
VANILLIN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VARITHENA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VARUBI Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VEKLURY Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VELPHORO Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VELTASSA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VEMLIDY Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
VENCLEXTA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart
